reference/22303765

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22303765

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	630
issn	2159-662X 0161-5505
issueIdentifier	5
pageRange	623-630
publicationName	Journal of nuclear medicine : official publication, Society of Nuclear Medicine
startingPage	623
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b25db40f168059a88e12271ee041c275 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e9bd26014304c5966e948e73a254cf8f
bibliographicCitation	Pryma DA, Chin BB, Noto RB, Dillon JS, Perkins S, Solnes L, Kostakoglu L, Serafini AN, Pampaloni MH, Jensen J, Armor T, Lin T, White T, Stambler N, Apfel S, DiPippo VA, Mahmood S, Wong V, Jimenez C. Efficacy and Safety of High-Specific-Activity ¹³¹I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma. J Nucl Med. 2018 Oct 05;60(5):623–30. doi: 10.2967/jnumed.118.217463.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0babd7bf54ed5fcf69b7d1aa4fad419f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afd996567cf53ccc94314a902eb0d5be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39435ae0d7857a2fc09d5b48f9cab6a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8de6433cfecc88a95dcb4cecb0fd6fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc21430fb41675a3d3a56473caf700f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9acc133dda2a1a81aa3fb0384dcd189a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb1454660ba4f6909f04b1a0a00f0c76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc89366e47224fdee88fed0b73918892 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f05ea120d23fc00747706487fad7adc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56a665a1f9ee0a98c3eebd1b39b362f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb992052afb9bb29bc1d310f263ebb7c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6acd5ac5489c04ffb3abe92a00521ab5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b1ee0e5a6ad04688a2d804c01334767 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db1fe1b6632fc4e015cd22188fcebe97 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5663dad0c04a8b176ab4e23817f9a29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_119304ed93b7158b9cbd4bfbdb120e5f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9b255ef2a24895c9a7c8543fb091bfd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6747faebeff3f9c306eaef1227673556 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2051d59cab9a8df8280f923e2d93f1c1
date	2018-10-05^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/30291194 https://doi.org/10.2967/jnumed.118.217463 https://pubmed.ncbi.nlm.nih.gov/PMC6495236
isPartOf	https://portal.issn.org/resource/ISSN/0161-5505 https://portal.issn.org/resource/ISSN/2159-662X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5045
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
discusses	http://id.nlm.nih.gov/mesh/M0029373 http://id.nlm.nih.gov/mesh/M0022149
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000310Q000532 http://id.nlm.nih.gov/mesh/D012449 http://id.nlm.nih.gov/mesh/D019797Q000627 http://id.nlm.nih.gov/mesh/D019797Q000009 http://id.nlm.nih.gov/mesh/D010235Q000532 http://id.nlm.nih.gov/mesh/D010673Q000532
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000310Q000378 http://id.nlm.nih.gov/mesh/D010673Q000378 http://id.nlm.nih.gov/mesh/D010235Q000378 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000310Q000473 http://id.nlm.nih.gov/mesh/D010673Q000473 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D010235Q000473 http://id.nlm.nih.gov/mesh/D014408Q000378 http://id.nlm.nih.gov/mesh/D016019
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7078 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71184 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8777 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8869 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60860

Showing number of triples: 1 to 73 of 73.